1.Exacerbation of Emesis and Dysphagia with Oxycodone Dose Escalation in a Patient with Lung Cancer, Possibly Associated with Complicated Esophageal Achalasia
Masahito Muramatsu ; Daisaku Nishimura ; Atsushi Masuda ; Tomoyuki Tsuzuki ; Natsuko Uematsu ; Saya Tanaka ; Yu Kondo
Palliative Care Research 2016;11(3):538-542
Objective: We describe a case of lung cancer complicated with esophageal achalasia (EA), which was successfully treated with endoscopic pneumatic dilation (EPD). Case: A 66-year-old woman was admitted to our hospital because of frequent episodes of emesis and dysphagia after receiving an escalating dose of sustained release oxycodone (SRO) for cancer-related multifactorial back pain. She had been diagnosed with EA and treated with EPD at the age of 50. Her symptoms were refractory to the conventional anti-emetic agents such as prochlorperazine and metoclopramide. Computed tomography imaging showed marked dilatation of the esophagus with food residue. We diagnosed EA based on the presence of rosette-like esophageal folds on endoscopy and narrowing of the esophagogastric junction on esophagography, and subsequently performed EPD, which alleviated the symptoms. Discussion: The effects of opioids on esophageal motility have not been elucidated thus far. Recent studies using high-resolution manometry reported that long-term use of opioids was associated with esophageal dysmotility similar to that observed in EA. Although we have no evidence to directly demonstrate the causal relationship between the use of SRO and anti-emetic agents and EA, we speculate that our patient’s symptoms might be associated not only with SRO-related emesis during the gradual worsening of EA, but also partly with the SRO-induced esophageal dysmotility and the constrictive effect of dopamine D2 receptor antagonists on the lower esophageal sphincter. Care must be taken to avoid drug-induced esophageal motor dysfunction, which might lead to deteriorate EA.
2.Appearance of Skin Moisturization in the Final Stage of life - A Prospective Observational Study with Clinical Pathway for End-of-Life Care (Liverpool Care Pathway Japanese Version) in Palliative Care Unit
Hiroaki SHIBAHARA ; Masahito MURAMATSU ; Takahisa NIWA ; Daisaku NISHIMURA
Journal of the Japanese Association of Rural Medicine 2015;64(2):131-139
Objective: To elucidate the appearance of skin moisturization (cold and clammy skin) indying period and related factors. Methods: Patients were observed prospectively with skin moisturization using the clinical pathway for end-of-life care (Liverpool Care Pathway Japanese version [LCP]) by nurses in the palliative care unit. Results: Of 213 patients placed on LCP, 48 (22.5%) indicated skin moisturization, which was observed mostly in summer and in the morning. It appeared 45.8 hours before death on the average. By multivariate analysis, the administration of non-steroidal anti-inflammatory drugs (NSAIDs) was an independent related factor. Conclusions: Compared to our previous retrospective study, the appearance of skin moisturization was higher in frequency and earlier in the dying period, and the administration of NSAIDs was an independent related factor.
3.The Relation between Self-Contribution Degree of Members of Palliative Care Team and Improvement in the Symptom Items Listed in STAS-J
Hiroaki SHIBAHARA ; Masahito MURAMATSU ; Daisaku NISHIMURA
Journal of the Japanese Association of Rural Medicine 2014;63(2):114-120
Purpose: To elucidate the degree of self-conctribution of each member of a palliative care team and the palliative effect patients. Patients and Methods:The degree of self-contribution to intervened patients and the degree of improvements in the symptoms items listed in a Japanese version of the Support Team Assessment Schedule (STAS-J) were examined prospectively. Results: The degree of self-contribution was often higher in doctors, nurses, clinical psychotherapists and pharmacists, and lower in nutritionists. It was related to age, gender, site of primary disease and the duration of intervention. The symptom items which showed improvement were such items as pain, nausea, vomiting, appetite loss and insomnia, but delirium and depression worsened. The degree of self-contribution and the degree of improvement in symptom were correlated in seven items in the case of pharmacists but only in one in the case of other professionals. Discussion: The degree of self-conribution varied and was not always high even after the intervention of the care team. It was considered that the fact that the number of related items was larger in pharmacists than in any other professionals was probably because the pharmacists could assess the symptoms and propose drugs from an objective point of view, although character might be mostly involved. Conslusion: It is to be hoped that every one engaged in palliative care will do what is one’s forte and apply each one’s individuality properly in the future.
4.Malignant Fibrous Histiocytoma Patient Who Survived for Over Five Months in Only Palliative Care Despite Marked Thrombocytopenia and Jaundice After Transferal to Our Hospital
Hiroaki SHIBAHARA ; Hironobu INAGAKI ; Daisaku NISHIMURA
Journal of the Japanese Association of Rural Medicine 2013;61(4):649-656
The patient was a woman in her 70s, who had been diagnosed as having a malignant fibrous histiocytoma in the right axilla with invasion to the intrathoracic space at a local hospital. The growth of cytokine-producing tumor was suspected, and thrombocytopenia caused by bleeding and jaundice by blood transfusion were disclosed. When she was admitted to our palliative care unit, the platelet count was 19,000/μl and total bilirubin was 6.4mg/dl. Furthermore, several predictive fools showed the prognosis for survival was poor. After transferal to our hospital, the patient was treated mainly with medication. No blood transfusion was given. In the clinical course, the platelet count and total bilirubin level were restored to normalcy. The patient lived on for another five months or over. The contributing factors, in prolonging her life longer than predicted were probably as follows; (1) spontaneous recovery of thrombocytopenia without bleeding, (2) improvement of jaundice caused by the blood transfusion, and (3) foods taken orally even in small amounts. There are patients whose prognosis varies substantially in the fields of the palliative care. It is important to work out proper medical treatment and care plans according to symptoms and the status of patients.
5.An Experience in Administration of EPA-Enriched Nutritional Supplementation (ProSurer®) for Lung Cancer Patients with Chemotherapy
Ayako YAMAMOTO ; Hiroaki SHIBAHARA ; Masahiro AOYAMA ; Kenichi NAKAHIRA ; Atsumi HAYASHI ; Daisaku NISHIMURA
Journal of the Japanese Association of Rural Medicine 2013;62(1):21-25
The initial case was a man in his 50s. He received 2 cans a day of ProSure®, while undergoing radiation and chemotherapy with carboplatin and docetaxel for adenocarcinoma in the lung. His body weight rose from 62.4 kg on admission to 63.7 kg before discharge, CRP decreased from 3.08 mg/dl to 0.48 mg/dl, and albumin fell from 3.6 g/dl to 3.5 g/dl. The second case was a man in his 60s. He was diagnosed as having squamous cell carcinoma in the lung and administered with 2 cans a day of ProSure® and antibiotics. One-and-a-half months later, he underwent chemotherapy with carboplatin and S-1 and radiation. His body weight stood at 47.0 kg on admission and 47.2 kg before discharge, CRP dropped from 15.45 mg/dl to 3.26 mg/dl, and albumin was retained at 2.6 g/dl to 2.7g/dl. The administration of ProSure® brought about improvements in the nutritional status and anti-inflammatory effects in the patients with chemotherapy.
6.A Case of Breast Carcinoma with Multiple Bone Metastases Intervened by Palliative Care Preceding Chemotherapy
Hiroaki SHIBAHARA ; Satoshi KOBAYASHI ; Ei SEKOGUCHI ; Yasuyuki FUKAMI ; Akira ITO ; Sakura ONISHI ; Akihiro TOMITA ; Ryo SHIRATSUKI ; Akira KANAMORI ; Kei MIYAMURA ; Yasuhiro KURUMIYA ; Daisaku NISHIMURA
Journal of the Japanese Association of Rural Medicine 2013;62(1):26-30
This case is a 56-year-old woman. With multiple bone metastases, she was referred to the Department of Palliative Care on the same day as core needle biopsy had just been performed in the Department of Surgery. Aggressively increased oxycodone was administered to relieve her significantly severe pains by bone metastases. After relief of the pains, cancer chemotherapy of EC and weekly PTX regimens were performed parallel to palliative care. In this case, chemotherapy could be performed after the pains had been sufficiently relieved with closer cooperation between the palliative care doctor and the attending surgeon. It is important for patient-focused medical care to be delivered by both the attending doctor administering cancer treatment and the palliative care doctor working for relief of the symptoms, while they are striving to foster their tie-up.
7.Pregabalin provides remarkable relief of refractory pruritus: a case report
Hiroaki Shibahara ; Akira Ando ; Daisaku Nishimura
Palliative Care Research 2013;8(1):507-510
Introduction: It is difficult in the treatment for the patients with refractory pruritus by conventional oral or external medication. Case report: A 72-year-old woman with pancreatic metastasis of primary lung cancer, who was treated by control-release oxycodone for cancer pain and endoscopic biliary drainage for obstructive jaundice. Although external medication and oral anti-allergic agents (mirtazapine and herbal medicine) were administered for pruritus, there was no improvement. The patient was diagnosed with refractory pruritus and pregabalin was administered. After the beginning of low dose, increase of dosage provided improvement at the third day of the administration. Finally, numerical rating scale improved from 8/10 in previous treatment to 0-1/10 in following treatment, and the symptom was relieved. Discussion: A few previous research of effectiveness on pregabalin for pruritus have been reported from abroad. The improvement for refractory pruritus was provided by pregabalin. Conclusion: We conclude that pregabalin is a one of the options for effective treatment for refractory pruritus.
8.Pigmentation by transdermal fentanyl patch
Hiroaki Shibahara ; Ei Sekoguchi ; Nagayuki Takeshita ; Shingo Suzuki ; Miho Morimoto ; Sachiko Inaguma ; Yoko Mori ; Sumiyo Kudo ; Yumi Ota ; Mika Nishimura ; Natsuko Uematsu ; Eri Imai ; Daisaku Nishimura
Palliative Care Research 2013;8(1):523-528
Introduction: There has been no case report in which hyperpigmentation developed on the skin area where a transdermal fentanyl patch was applied in a patient. Case report: A 43-year-old man with recurrence of postoperative rectal cancer was treated by cetuximab plus irinotecan and panitumumab plus FOLFIRI. For cancer pain, transdermal fentanyl patch (Fentos®) was administered, and radiation from behind was performed. Hyperpigmentation then appeared on the chest and the abdominal skin sites where the patches were applied. The hyperpigmentation nearly disappeared four months after the fentanyl patch was discontinued. Discussion: The cause of the pigmentation was possibly due to post inflammatory hyperpigmentation secondary to contact dermatitis. It was desirable to conduct patch test and skin biopsy for making an accurate diagnosis. Conclusion: We should pay a careful attention to hyperpigmentation of the skin where a transdermal fentanyl patch is applied.
9.Successful Pain Control in Cancer Patient on Palliative Therapy by Partial Opioid Rotation
Natsuko UEMATSU ; Hiroaki SHIBAHARA ; Taeko OKAMOTO ; Sanae KINOSHITA ; Kaori MANO ; Masahiro AOYAMA ; Daisaku NISHIMURA ; Akira ITO ; Atsushi YOSHIDA
Journal of the Japanese Association of Rural Medicine 2012;60(6):764-769
Our palliative care team intervened in a patient with sciatica resulting from metastasis to sacral bone after surgery for rectal cancer. Rapid pain control and a change in the route of rescue drug administration from the stoma were needed. Partial opioid rotation was performed. The dose of 25.2 mg in 72 hours in a transdermal fentanyl patch decreased to 16.8 mg in 72 hours, and the dose of 3.6mg in an hour by continuous intravenous injection of morphine was added. The change in the rescue root to intravenous administration by a patient-controlled analgesia pump gave the patient relief from his pain. He was able to attend his daughter's wedding. His family were all pleased with the relief provided. The advantages of this partial opioid rotation are summed up in the following three points: (1) The required time is relatively short; (2) It can be expedient for analgesia due to the addition of different opioids; and (3) The partial opioid rotation produces fewer adverse effects than a full opioid rotation. Adjustment of the amount of drugs for pain relief in cancer patients is important with the situations of the patient and the family taken into consideration fully.
10.Significance of Mini-Lecture in ‘Cancer Salon-Kirameki’
Hiroshi SHIBAHARA ; Tatsuya SUGIMURA ; Daisaku NISHIMURA
Journal of the Japanese Association of Rural Medicine 2012;61(1):39-44
Background: In our hospital, a mini-lecture is given before a social gathering during “Cancer Salon-”
Purpose: To examine Significance of the mini-lecture.
Method: The results of a questionnaire survey of the participants were summarized.
Results: The mini-lectures were performed by multidisciplinary persons. The survey found that a significantly large number of the participants felt the mini-lectures by persons other than medical doctors were helpful (p=0.021).
Discussion: Mini-lectures are valuable in that they provide not only information but also “create an atmosphere” of the following meeting. In addition, to receive a favorable assessment from the audience, it is important for the speakers, even the doctors, to understand the feelings of the participants, and take part in the subsequent get-together without formality.
Conclusion: The mini-lecture creates an atmosphere toward the social gatherings, and leads the speakers to adapt to the occasion with the participants.


Result Analysis
Print
Save
E-mail